-Roger J Hajjar Researcher Activity Profile

Research Author Detailed Information 

Roger J Hajjar Publication Rate By Year

Roger J Hajjar has published 1 paper(s) in 2000, 2 paper(s) in 2006, 20 paper(s) in 2007, 7 paper(s) in 2008, for a total of 30 research publications in total.

Roger J Rj Hajjar Author Information

LAST NAME: hajjar

FIRST NAME: Roger J

INITIALS: rj

AFFILIATION:

Papers

Roger J Hajjar's Publication Record

1. Restoration of mechanical and energetic function in failing aortic-banded rat hearts by gene transfer of calcium cycling proteins. Year Published: 2007
Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02114, USA.
2. Toll-like receptor 2 activation by bacterial peptidoglycan-associated lipoprotein activates cardiomyocyte inflammation and contractile dysfunction. Year Published: 2007
Department of Anesthesia and Critical Care, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
3. Gene therapy in the treatment of heart failure. Year Published: 2007
Cardiology Division, Cardiovascular Research Center, the Cardiology Laboratory of Integrative Physiology, Imaging at Massachusetts General Hospital, Boston, MA, USA.
4. Three catheter-based strategies for cardiac delivery of therapeutic gelatin microspheres. Year Published: 2006
Cardiology Laboratory for Integrative Physiology and Imaging, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. kozo@kyoto-u.ac.jp
5. Localization and quantification of platelet-rich thrombi in large blood vessels with near-infrared fluorescence imaging. Year Published: 2007
Division of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Boston, MA 02215, USA. rflaumen@bidmc.harvard.edu
6. Mechanisms of abnormal calcium homeostasis in mutations responsible for catecholaminergic polymorphic ventricular tachycardia. Year Published: 2007
Cardiovascular Research Center, Massachusetts General Hospital, Charlestown, MA 02129, USA.
7. Transcoronary gene transfer of SERCA2a increases coronary blood flow and decreases cardiomyocyte size in a type 2 diabetic rat model. Year Published: 2007
Cardiovascular Research Center, Massachusetts General Hospital, 149 13th St., CNY-4, Charlestown, MA 02129, USA.
8. Targeted gene transfer increases contractility and decreases oxygen cost of contractility in normal rat hearts. Year Published: 2007
Mount Sinai School of Medicine, Atran Laboratory Building, One Gustave L. Levy Place, Box 1030, New York, NY 10029-6574, USA.
9. Gene profiling during regression of pressure overload-induced cardiac hypertrophy. Year Published: 2007
Department of Life Science, Gwangju Institute of Science and Technology, Gwangju, Korea.
10. Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Year Published: 2007
Department of Cardiology, Children's Hospital Boston, 300 Longwood Avenue, Boston, Massachusetts 02115, USA. bernhard.kuhn@cardio.chboston.org
11. Early repair of moderate ischemic mitral regurgitation reverses left ventricular remodeling: a functional and molecular study. Year Published: 2007
Cardiac Ultrasound Laboratory, Cardiovascular Research Center, and Cardiothoracic Surgery Department, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
12. Preservation of mechanical and energetic function after adenoviral gene transfer in normal rat hearts. Year Published: 2007
Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA. ssakata@naramed-u.ac.jp
13. AAV vectors and cardiovascular disease: Targeting TNF receptor in the heart: clue to way forward with AAV? Year Published: 2007
14. AAV vectors and cardiovascular disease: targeting TNF receptor in the heart: clue to way forward with AAV? Year Published: 2007
15. Combining neuroendocrine inhibitors in heart failure: reflections on safety and efficacy. Year Published: 2007
Division of Cardiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. Jneid.Hani@mgh.harvard.edu
16. Gene therapy: targeting the myocardium. Year Published: 2007
Department of Cardiac Medicine, National Heart and Lung Institute, Dovehouse Street, London, SW3 6LY, UK; a.lyon@ic.ac.uk.
17. Gene therapy: targeting the myocardium. Year Published: 2007
Department of Cardiac Medicine, National Heart and Lung Institute, Dovehouse Street, London, SW3 6LY, UK. a.lyon@ic.ac.uk
18. Combining neuroendocrine inhibitors in heart failure: reflections on safety and efficacy. Year Published: 2007
Division of Cardiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. Jneid.Hani@mgh.harvard.edu
19. Cardiac sodium channel gene variants and sudden cardiac death in women. Year Published: 2008
Center for Arrhythmia Prevention, Division of Preventive Medicine, Brigham and Women's Hospital and Harvard Medical School, 900 Commonwealth Ave E, Boston, MA 02215-1204, USA. calbert@partners.org
20. Cardiac sodium channel gene variants and sudden cardiac death in women. Year Published: 2008
Center for Arrhythmia Prevention, Division of Preventive Medicine, Brigham and Women's Hospital and Harvard Medical School, 900 Commonwealth Ave E, Boston, MA 02215-1204, USA. calbert@partners.org
21. Combining neuroendocrine inhibitors in heart failure: reflections on safety and efficacy. Year Published: 2007
Division of Cardiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. Jneid.Hani@mgh.harvard.edu
22. Gene therapy: targeting the myocardium. Year Published: 2007
Department of Cardiac Medicine, National Heart and Lung Institute, Dovehouse Street, London, SW3 6LY, UK. a.lyon@ic.ac.uk
23. Cardiac sodium channel gene variants and sudden cardiac death in women. Year Published: 2008
Center for Arrhythmia Prevention, Division of Preventive Medicine, Brigham and Women's Hospital and Harvard Medical School, 900 Commonwealth Ave E, Boston, MA 02215-1204, USA. calbert@partners.org
24. Mitral regurgitation augments post-myocardial infarction remodeling failure of hypertrophic compensation. Year Published: 2008
Cardiac Ultrasound Laboratory, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.
25. Preservation of mechanical and energetic function after adenoviral gene transfer in normal rat hearts. Year Published: 2007
Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA. ssakata@naramed-u.ac.jp
26. The promise of gene therapy as a therapeutic modality in heart failure. Year Published: 2000
Program in Cardiovascular Gene Therapy, Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA. hajjar@cvrc.mgh.harvard.edu
27. Gene and cell therapy in heart failure. Year Published: 2006
Massachusetts General Hospital, Boston, MA, USA.
28. Intracellular devastation in heart failure. Year Published: 2008
Cardiovascular Research, Beth Israel Deaconess Medical Center, 330 Brookline Ave., Boston, MA, 02215, USA, fdelmont@bidmc.harvard.edu.
29. PICOT Attenuates Cardiac Hypertrophy by Disrupting Calcineurin-NFAT Signaling. Year Published: 2008
Department of Life Science, Gwangju Institute of Science and Technology, 1 Oryong-dong, Buk-gu, Gwangju, 500-712, Korea. wjpark@gist.ac.kr.
30. PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling. Year Published: 2008
Global Research Laboratory and Department of Life Science, Gwangju Institute of Science and Technology, Gwangju, Korea.